Please use this identifier to cite or link to this item: http://20.193.157.4:9595/xmlui/handle/123456789/4409
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKhot, AM-
dc.contributor.authorChaukimath, S P-
dc.contributor.authorJanagond, Ajit-
dc.contributor.authorHugar, Leela-
dc.date.accessioned2022-09-13T05:07:08Z-
dc.date.available2022-09-13T05:07:08Z-
dc.date.issued2020-
dc.identifier.urihttp://hdl.handle.net/123456789/4409-
dc.description.abstractCutaneous adverse drug reactions (CADRs) are common, comprise approximately 2-3% of all the ADRs. Most of them are mild, self-limiting. Severe and potentially life-threatening eruptions occur in approximately 1 in 1000 hospitalised patients. Which carry a high degree of morbidity & mortality. Hence early detection, evaluation and monitoring of ADRs in particular CADRs are essential. As the pattern of CADRs is changing every year with the introduction of new medications & evolving prescription practices. To determine the pattern of various types of CADRs & to identify causative drug implicated in our setup, this study was carried out. A retrospective analysis of the CADRs retrieved from the Pharmacovigilance centre database, reported spontaneously between 25thAug 2015 to 31stOct 2019. The CADRs obtained were categorized according to their morphology & the suspected drugs were grouped according to ATC classification. Causality, severity & preventability assessment was done by using pretested scales. 70 patients had CADRs with male to female ratio of 1:2. Urticaria (37.14%) was the most common CADR & 5.7% of the CADRs were severe. Anti-infectives for systemic use (48.6%) was predominantly involved in the causation of CADRs. Most of the CADRs belong to a possible category, 75% of them were either recovered or recovering at the time of reporting & only 25% of the CADRs are preventable. Pattern of ACDRs & the drugs causing them are slightly different in our population as compared to other previous studies. Which emphasizes the need for robust ADR monitoring system in our setup.en_US
dc.language.isoenen_US
dc.publisherBLDE(DU)en_US
dc.subjectCutaneous adverse drug reactionsen_US
dc.subjectPharmacovigilanceen_US
dc.subjectUrticaria.en_US
dc.titleA Study of Cutaneous Adverse Drug Reactions; Clinical/ Morphological Pattern & Causative Agents Reported in an ADR Monitoring Centre in a Tertiary Care Hospital of North Karnatakaen_US
dc.typeArticleen_US
Appears in Collections:Faculty of Pharmacology

Files in This Item:
File Description SizeFormat 
Scopus 2020 Leela Hugar.pdf453.68 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.